|
Re: Pulmonary Hypertension News
|
7
|
Resverlogix Corp.
|
Mar 21, 2019 06:40PM
|
|
Re: Prospects for resverlogix
|
10
|
Resverlogix Corp.
|
Jul 15, 2020 11:47AM
|
|
Re: Promissory Notes
|
6
|
Zenith Epigenetics
|
Sep 22, 2021 08:09PM
|
|
Re: Promissory Note
|
2
|
Zenith Epigenetics
|
Jan 30, 2021 05:21PM
|
|
Re: Promissory Note
|
4
|
Zenith Epigenetics
|
Jan 31, 2021 01:47PM
|
|
Re: Promissory Note
|
4
|
Zenith Epigenetics
|
Jan 31, 2021 02:39PM
|
|
Re: Promissory Note
|
1
|
Zenith Epigenetics
|
Mar 10, 2021 01:17PM
|
|
Re: Probably one of the most important days for RVX
|
6
|
Resverlogix Corp.
|
Nov 13, 2019 12:44PM
|
|
Re: Presentation up on YouTube
|
8
|
Resverlogix Corp.
|
Sep 24, 2020 05:23PM
|
|
Re: Presentation is up again
|
7
|
Resverlogix Corp.
|
May 18, 2021 01:42PM
|
|
Re: Presentation is gone
|
4
|
Resverlogix Corp.
|
May 14, 2021 02:27PM
|
|
Re: Presentation by James Hudson
|
3
|
Resverlogix Corp.
|
Apr 28, 2021 03:02PM
|
|
Re: PP
|
2
|
Zenith Epigenetics
|
Aug 26, 2020 05:12PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
4
|
Resverlogix Corp.
|
Nov 14, 2022 05:46PM
|
|
Re: Potential market
|
5
|
Resverlogix Corp.
|
Nov 17, 2019 02:51PM
|
|
Re: Potential market
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 03:55PM
|
|
Re: Posted this to social media...
|
5
|
Resverlogix Corp.
|
Oct 29, 2020 11:49AM
|
|
Re: Positives vs. negatives
|
2
|
Resverlogix Corp.
|
Nov 20, 2019 05:02PM
|
|
Re: Please hurry RVX
|
6
|
Resverlogix Corp.
|
Apr 16, 2021 12:34PM
|
|
Re: Pfizer's plans for research: sounds like RVX!
|
2
|
Resverlogix Corp.
|
Jan 29, 2020 02:30PM
|
